NeuBase is currently in the preclinical drug development phase of delivering precision genetic medicines for myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancers driven by KRAS G12D and G12V mutations. If you would like to stay informed of our progress, please sign up for updates.
Keep me updatedIf you or a person you know have been diagnosed with myotonic dystrophy, type 1 (DM1) or Huntington's disease (HD), we have listed below organizations that provide resources and services for patients, family members, caregivers, and supporters. Click on the logo to be taken to each organization's website.
Huntington's Disease Youth Organization (HDYO) is dedicated to supporting those under 35 who are impacted by the disease, including patients with the juvenile form of HD, pre-manifest patients, and children of those affected by the disease.